HYDERABAD: India will soon be releasing the policy document on the booster dose (third dose) vaccine Covid-19, a key member of the task force Covid nations said on Thursday.
Dr NK Arora, co-chair of INSACOG, 28-lab consortium formed to monitor variations in the genome of the SARS-CoV-2, urging people not to take a dose booster now because it will not be considered for each certification.
“We have been working on a policy document over the past three weeks, and firming it.
It will be made public as soon as possible, “said Arora.
In timesnow summit in Delhi, Union health minister Mansukh Mandaviya say that it is natural to discuss the need for booster shots but the government would take a decision based on expert opinion.
“Our goal is to first manage both the first dose and the second dose for the whole population eligible.
I do not think that in such matters (booster dose), the government will take a direct decision …
we will be dependent on any recommendation given by the ICMR and the team of experts.
We will deliberate on the matter only after the expert advice received, “said Mandaviya.
He added that the country has sufficient doses available and, therefore, future requirements can be met.
The document, which is likely to be out in 10 days, will outline the government’s plans on rolling out the third dose and those who are eligible to get it first.
“We are manufacturing a dose of 30-35 crore every month.
We do not have a shortage of the vaccine, but that does not mean you take care of them without reason.
There are many scientific thinking into the document, “said Arora.
Warning people do not go in for a third dose of yet, he said all seropositive study across the country have shown the vaccine is given so far worked well, and no major outbreak should be a quick panic and rush for vaccinations secret.
“There will be no record of the third dose is that people take quietly,” Arora told TOI.
Read AlsoCovaxin well tolerated, phase 3 data showed 77.8% efficacy against symptoms Covid: Lanceta weeks after the World Health Organization (WHO) awarded Use Emergency Listing (Eul) to Covaxin, the prestigious medical journal The Lancet stated that the Phase 3 Data India vaccine native first developed showed 77.8% efficacy against symptoms Covid-19.
Its efficacy data alsoArora comments came as various officials, including health authorities Telangana, has openly advocated the third dose, said people who are low on immunity had to take booster shot.
“There is no such arrangement in COWIN.
And you will not get a certificate.
In addition, there is no outbreak, and no great concern because the case fell.
We are in a better situation than many other countries, “said Arora.
Read AlsoNumber people still take the ramp shot vaccine for 12 crore, said the health minister Mansukh MandaviyaOver 12 crore people are due for a second dose of their vaccines Covid in India, the health minister Mansukh Mandaviya show when he urged countries to make collective efforts to ensure it does not No citizen left without vaccine protection.
The number of people who are late for a second dose has been increased as Dr V KSO far, studies of seropositive over India have shown that vaccination has had a positive impact, with at least 85% of the beneficiaries are entitled India received at least one dose.
“In Delhi, 97% of the population is seropositive.
In UP, the figure is 88% and 85% in Telangana.
Vaccination drive in full swing, “Arora said, adding that the vaccine tracker shows that even those who have received the first dose only protected from death.
He said India plans to bridge the gap between the two doses Covishield has gone a long way in ensuring protection.
“We are now reaping the benefits.
India antibody levels between the higher of (in) others, “he said.
After Dussehra, barring a few cases in West Bengal, Assam and Himachal Pradesh, there is no reason for concern.
“Dussehra is celebrated everywhere.
But look, we do not have a major concern so far, “he added.